The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Jeremy J. Butler - Abstracts
| The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Jeremy J. Butler | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| A. Schulman Inc.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| A. Schulman Inc.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Barr Pharm., Inc.(stock price appreciation potential; Barr Pharmaceuticals Inc.) | Business, general | Jeremy J. Butler | |||
| Biogen Idec.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Bristol-Myers Sq.(stock price appreciation potential; Bristol-Myers Squibb Co.) | Business, general | Jeremy J. Butler | |||
| Chemical (basic) industry.(analysis of securities) | Business, general | Mario Ferro, Jeremy J. Butler, Robert Mitkowski, Adam Rosner, Michael F. Napoli, Dominic B. Silva | |||
| Chemical (basic) industry.(securities analysis) | Business, general | Mario Ferro, Jeremy J. Butler, Robert Mitkowski, Adam Rosner, Michael F. Napoli, Dominic B. Silva | |||
| Chemical/diversified industry.(analysis of securities) | Business, general | Alan G. House, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Susan J. Ferrara | |||
| Chemical/diversified industry.(analysis of securities) | Business, general | Alan G. House, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Susan J. Ferrara | |||
| Chemical (specialty).(analysis of securities) | Business, general | Charles Clark, Jeremy J. Butler, Adam Rosner, Frederick L. Harris, Simon R. Shoucair, Jason A. Smith, Lester Ratcliff, Ian Gendler, Erik A. Antonson, Bryan Fong | |||
| Chevron Corp.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Chevron Corp.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Covance, Inc.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Drug industry. | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(analysis of securities) | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, Frederick L. Harris, Susan J. Ferrara, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(securities analysis as of July 20, 2007)(Industry overview) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes | |||
| Dynegy, Inc.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Dynegy, Inc.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Entertainment industry.(analysis of securities) | Business, general | Damon Churchwell, Sigourney B. Romaine, Jeremy J. Butler, Simon R. Shoucair, Reuben Gregg Brewer, Dominic B. Silva, John D. Burke | |||
| Entertainment industry.(analysis of securities) | Business, general | Damon Churchwell, Sigourney B. Romaine, Jeremy J. Butler, Simon R. Shoucair, Reuben Gregg Brewer, Dominic B. Silva, John D. Burke | |||
| Fuller (H.B.).(H.B. Fuller Co.)(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Fuller (H.B.).(stock price appreciation potential)(H.B. Fuller Co.)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Genzyme Corp.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| GlaxoSmithK.(stock price appreciation potential; GlaxoSmithKline plc ) | Business, general | Jeremy J. Butler | |||
| Material Sciences.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Material Sciences.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Mylan Inc.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Natural gas (diversified) industry.(analysis of securities) | Business, general | Jeremy J. Butler, Adam Rosner, Frederick L. Harris, Simon R. Shoucair, Jason A. Smith, Michael F. Napoli, Dominic B. Silva | |||
| Natural gas (diversified) industry.(securities' analysis) | Business, general | Jeremy J. Butler, Adam Rosner, Frederick L. Harris, Simon R. Shoucair, Michael F. Napoli, Dominic B. Silva, Orly Seidman | |||
| Nektar Therap'tics.(stock price appreciation potential; Nektar Therapeutics ) | Business, general | Jeremy J. Butler | |||
| Newspaper industry.(analysis of securities) | Business, general | George Rho, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Richard Gallagher, Orly Seidman | |||
| Newspaper industry.(anlaysis of securities) | Business, general | George Rho, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Richard Gallagher, Orly Seidman | |||
| NOVA Chemicals.(stock price appreciation potential; NOVA Chemicals Corp.) | Business, general | Jeremy J. Butler | |||
| Novartis AG.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Park Electrochem.(Park Electrochemical Corp.)(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Park Electrochem.(Park Electrochemical Corp.)(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Petroleum (integrated) industry.(analysis of securities) | Business, general | Jeremy J. Butler, Robert Mitkowski, Michael P. Maloney, Frederick L. Harris, Michael F. Napoli | |||
| Petroleum (integrated) industry.(securities' analysis) | Business, general | Jeremy J. Butler, Robert Mitkowski, Michael P. Maloney, Frederick L. Harris, Jason A. Smith, Michael F. Napoli | |||
| Petroleum (producing) industry.(analysis of securities) | Business, general | Warren Thorpe, Jeremy J. Butler, Robert Mitkowski, Simon R. Shoucair, Garrett Sussman | |||
| Petroleum (producing) industry.(analysis of securities) | Business, general | Jeremy J. Butler, Robert Mitkowski, Simon R. Shoucair, Garrett Sussman, Orly Seidman | |||
| Pharma Prod.(stock price appreciation potential; Pharmaceutical Product Development Inc.) | Business, general | Jeremy J. Butler | |||
| Publishing industry.(analysis of securities) | Business, general | Sigourney B. Romaine, Jeremy J. Butler, Morton L. Siegel, Simon R. Shoucair, Orly Seidman | |||
| Sigma-Aldrich.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Sigma-Aldrich.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| Tesoro Corp.(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Tesoro Corp.(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
| The Brink's Co. | Business, general | Jeremy J. Butler | |||
| The Brink's Co.(analysis of securities) | Business, general | Jeremy J. Butler | |||
| Valspar Corp. (The).(stock price appreciation potential) | Business, general | Jeremy J. Butler | |||
| Valspar Corp. (The).(stock price appreciation potential)(Analyst report) | Business, general | Jeremy J. Butler | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.